Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-20T18:52:33.087Z Has data issue: false hasContentIssue false

Pituitary Responses to a Neuroactive Tripeptide (TRH) in Friedreich’s Ataxia Families

Published online by Cambridge University Press:  18 September 2015

G. Tolis
Affiliation:
Department of Medicine, Division of Endocrinology Royal Victoria Hospital
A. Mehta
Affiliation:
Department of Medicine, Division of Endocrinology Royal Victoria Hospital
E. Andermann
Affiliation:
Department of Neurogenetics, Montreal Neurological Hospital and Institute, McGill University
C. Harvey
Affiliation:
Department of Neurogenetics, Montreal Neurological Hospital and Institute, McGill University
A. Barbeau*
Affiliation:
Institut de recherches cliniques de Montréal, Montréal, Quebec, Canada
*
Prof. André Barbeau, Clinical Research Institute of Montreal, 110 West Pine Avenue West, Montréal, Quebec, Canada H2W 1R7
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Oral glucose tolerance, thyroid function tests, as well as thyrotropin, prolactin and growth hormone release after administration of thyrotropin releasing hormone, were evaluated in patients with Friedreich’s ataxia and unaffected family members. Impaired glucose tolerance was found in the majority of family members, affected or not. Thyroid hormone levels and PRL and TSH responses to TRH, were similar in all and normal. However, GH responses to TRH were abnormal in half of the patients, but in none of the unaffected family members. Paradoxical responses to neuropeptides may characterize some Friedreich’s ataxia patients, and may predict the possibility of therapeutic maneuvers with such peptides in these patients.

Type
Research Article
Copyright
Copyright © Canadian Neurological Sciences Federation 1982

References

REFERENCES

Bastomsky, C., Dent, R., Tolis, G. (1977). Elevated serum TBG and ceruloplasmin in methadone maintained patients. Clin. Biochem. 10(3): 124126.CrossRefGoogle Scholar
Chase, T.N., Woods, A.C., Lipton, M.A.Morris, C.E. (1974). Hypothalamic releasing factors and Parkinson’s disease. Arch. Neurol., 31, 5556.CrossRefGoogle Scholar
Faden, A.I., Jacobs, T.P., Holaday, J.W. (1981). TRH improves neurologic recovery after spinal trauma in cats. N.E. J.M.,305: 10631067.CrossRefGoogle Scholar
Jarrell, J., Meltzer, S., Tolis, G. (1979). Anorexia nervosa: a review of the endocrine abnormalities in the hypothalamic pituitary axis, in: Clinical Neuroendrocinology – a pathophysiological approach. (Tolis, G., Labrie, F., Martin, J.B. and Naftolin, F., eds.). Raven Press, New York, pp. 355365.Google Scholar
Mehta, A., Tolis, G. (1979). Bromocriptine. Drugs 17:313325.CrossRefGoogle ScholarPubMed
Pieters, G.F., Smals, A.G., Benraad, T.J., Kloppenborg, P.W.C. (1979). Plasma Cortisol responses to TRH and LHRH in Cushing’s disease. J. Clin. Endocrinol. Metab. 48: 874876.CrossRefGoogle ScholarPubMed
Prange, A.J. Jr., Wilson, I.C., Lara, P.P., Alltop, L.B., Brease, G.R. (1972). Effects of TRH in depression. Lancet, 2:9991002.CrossRefGoogle Scholar
Reichlin, S. (1979). Overview of the anatomical and physiologic basis of anterior-pituitary regulation, in: Clinical Neuroendrocrinology – a pathophysiological approach. (Tolis, G., Labrie, F., Martin, J.B. and Naftolin, F., eds.) Raven Press, New York, pp. 114.Google Scholar
Sobue, I., Yamamoto, H., Konagaya, M., Lida, M., Takayanagi, T. (1980). Effect of TRH on ataxia of spino-cerebellar degeneration. Lancet 1, 418419.CrossRefGoogle Scholar
Tolis, G., Martin, J.B.Kovacs, L., Friesen, H.G. (1975). GH and PRL secretory pattern in active acromegaly. Acta Endocrinol. 78:251257.Google Scholar
Tolis, G., Banovac, K., Mackenzie, J.M., Guyda, H. (1979). Circadian rhythms of anterior pituitary hormone secretion. J. Endocrinol. Invest. 2: 433436.CrossRefGoogle ScholarPubMed
Tolis, G., Mckenzie, J.M., Martin, J.B., Bertrand, G. (1979). Growth hormone secreting pituitary tumors: Clinical presentation, diagnostic tests and therapeutic modalities. In: Clinical Neuroendocrinology – a pathophysiological approach. (Tolis, G., Labrie, F., Martin, J.B. and Naftolin, F., eds.) Raven Press, New York, pp. 437448.Google Scholar
Tolis, G., Mehta, A., Andermann, E., Harvey, C., Barbeau, A. (1980). Friedreich’s ataxia and oral glucose tolerance. Can. J. Neurol. Sci. 7(4): 397400.CrossRefGoogle ScholarPubMed